nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—CYP3A4—Disulfiram—alcohol dependence	0.0222	0.584	CbGbCtD
Orlistat—CYP3A4—Citalopram—alcohol dependence	0.0158	0.416	CbGbCtD
Orlistat—LIPF—digestive system—alcohol dependence	0.0142	0.054	CbGeAlD
Orlistat—DAGLA—forebrain—alcohol dependence	0.013	0.0496	CbGeAlD
Orlistat—LIPF—testis—alcohol dependence	0.0112	0.0426	CbGeAlD
Orlistat—DAGLA—blood—alcohol dependence	0.00873	0.0332	CbGeAlD
Orlistat—DAGLA—testis—alcohol dependence	0.00722	0.0274	CbGeAlD
Orlistat—ABHD16A—adrenal cortex—alcohol dependence	0.0071	0.027	CbGeAlD
Orlistat—DAGLA—nervous system—alcohol dependence	0.00708	0.0269	CbGeAlD
Orlistat—PLA2G7—cardiovascular system—alcohol dependence	0.00691	0.0263	CbGeAlD
Orlistat—DAGLA—central nervous system—alcohol dependence	0.00682	0.0259	CbGeAlD
Orlistat—DAGLA—cerebellum—alcohol dependence	0.00667	0.0253	CbGeAlD
Orlistat—ABHD12—adrenal cortex—alcohol dependence	0.00666	0.0253	CbGeAlD
Orlistat—ABHD16A—pancreas—alcohol dependence	0.0063	0.024	CbGeAlD
Orlistat—PNLIP—cardiovascular system—alcohol dependence	0.00608	0.0231	CbGeAlD
Orlistat—PNLIP—pancreas—alcohol dependence	0.00591	0.0225	CbGeAlD
Orlistat—DAGLB—testis—alcohol dependence	0.0056	0.0213	CbGeAlD
Orlistat—PLA2G7—blood—alcohol dependence	0.00546	0.0208	CbGeAlD
Orlistat—DAGLA—brain—alcohol dependence	0.00541	0.0206	CbGeAlD
Orlistat—PLA2G7—midbrain—alcohol dependence	0.0054	0.0205	CbGeAlD
Orlistat—DAGLB—liver—alcohol dependence	0.00529	0.0201	CbGeAlD
Orlistat—DAGLB—cerebellum—alcohol dependence	0.00517	0.0196	CbGeAlD
Orlistat—Ethanolamine Oleate—CYP2E1—alcohol dependence	0.00516	1	CrCbGaD
Orlistat—ABHD16A—blood—alcohol dependence	0.00513	0.0195	CbGeAlD
Orlistat—ABHD16A—midbrain—alcohol dependence	0.00506	0.0192	CbGeAlD
Orlistat—PNLIP—digestive system—alcohol dependence	0.00504	0.0192	CbGeAlD
Orlistat—PNLIP—blood—alcohol dependence	0.0048	0.0183	CbGeAlD
Orlistat—ABHD12—blood—alcohol dependence	0.0048	0.0183	CbGeAlD
Orlistat—ABHD12—midbrain—alcohol dependence	0.00474	0.018	CbGeAlD
Orlistat—PLA2G7—endocrine gland—alcohol dependence	0.00474	0.018	CbGeAlD
Orlistat—PLA2G7—liver—alcohol dependence	0.00427	0.0162	CbGeAlD
Orlistat—ABHD16A—testis—alcohol dependence	0.00424	0.0161	CbGeAlD
Orlistat—DAGLB—brain—alcohol dependence	0.0042	0.016	CbGeAlD
Orlistat—PNLIP—endocrine gland—alcohol dependence	0.00417	0.0158	CbGeAlD
Orlistat—FASN—blood—alcohol dependence	0.00403	0.0153	CbGeAlD
Orlistat—FASN—midbrain—alcohol dependence	0.00398	0.0151	CbGeAlD
Orlistat—ABHD12—testis—alcohol dependence	0.00397	0.0151	CbGeAlD
Orlistat—ABHD16A—cerebellum—alcohol dependence	0.00392	0.0149	CbGeAlD
Orlistat—PNLIP—liver—alcohol dependence	0.00376	0.0143	CbGeAlD
Orlistat—ABHD12—liver—alcohol dependence	0.00376	0.0143	CbGeAlD
Orlistat—ABHD12—cerebellum—alcohol dependence	0.00367	0.014	CbGeAlD
Orlistat—PLA2G7—brain—alcohol dependence	0.00339	0.0129	CbGeAlD
Orlistat—FASN—testis—alcohol dependence	0.00334	0.0127	CbGeAlD
Orlistat—FASN—liver—alcohol dependence	0.00315	0.012	CbGeAlD
Orlistat—FASN—cerebellum—alcohol dependence	0.00308	0.0117	CbGeAlD
Orlistat—ABHD12—brain—alcohol dependence	0.00298	0.0113	CbGeAlD
Orlistat—PLA2G4A—adrenal cortex—alcohol dependence	0.00269	0.0102	CbGeAlD
Orlistat—FASN—brain—alcohol dependence	0.0025	0.00951	CbGeAlD
Orlistat—PLA2G4A—cardiovascular system—alcohol dependence	0.00245	0.00932	CbGeAlD
Orlistat—Urine output increased—Acamprosate—alcohol dependence	0.00236	0.00461	CcSEcCtD
Orlistat—Diabetes mellitus—Acamprosate—alcohol dependence	0.00218	0.00426	CcSEcCtD
Orlistat—Polyuria—Acamprosate—alcohol dependence	0.00216	0.00422	CcSEcCtD
Orlistat—Eczema—Acamprosate—alcohol dependence	0.00211	0.00412	CcSEcCtD
Orlistat—Sleep disorder—Naltrexone—alcohol dependence	0.00207	0.00405	CcSEcCtD
Orlistat—Increased appetite—Acamprosate—alcohol dependence	0.00202	0.00394	CcSEcCtD
Orlistat—Thirst—Acamprosate—alcohol dependence	0.00199	0.00389	CcSEcCtD
Orlistat—Dermatitis bullous—Acamprosate—alcohol dependence	0.00198	0.00387	CcSEcCtD
Orlistat—Arthritis—Acamprosate—alcohol dependence	0.00195	0.00381	CcSEcCtD
Orlistat—PLA2G4A—blood—alcohol dependence	0.00194	0.00737	CbGeAlD
Orlistat—PLA2G4A—midbrain—alcohol dependence	0.00191	0.00728	CbGeAlD
Orlistat—Increased appetite—Naltrexone—alcohol dependence	0.00191	0.00373	CcSEcCtD
Orlistat—Menopausal symptoms—Naltrexone—alcohol dependence	0.0019	0.00371	CcSEcCtD
Orlistat—Thirst—Naltrexone—alcohol dependence	0.00188	0.00368	CcSEcCtD
Orlistat—Acne—Citalopram—alcohol dependence	0.00186	0.00363	CcSEcCtD
Orlistat—Arthritis—Naltrexone—alcohol dependence	0.00185	0.0036	CcSEcCtD
Orlistat—Cardiovascular disorder—Citalopram—alcohol dependence	0.00178	0.00348	CcSEcCtD
Orlistat—Amenorrhoea—Citalopram—alcohol dependence	0.00178	0.00348	CcSEcCtD
Orlistat—Dry skin—Acamprosate—alcohol dependence	0.00174	0.00339	CcSEcCtD
Orlistat—Rectal haemorrhage—Citalopram—alcohol dependence	0.00173	0.00338	CcSEcCtD
Orlistat—Dysmenorrhoea—Citalopram—alcohol dependence	0.00172	0.00336	CcSEcCtD
Orlistat—Arthropathy—Citalopram—alcohol dependence	0.00172	0.00336	CcSEcCtD
Orlistat—Breast disorder—Acamprosate—alcohol dependence	0.00171	0.00334	CcSEcCtD
Orlistat—Paraesthesia—Disulfiram—alcohol dependence	0.0017	0.00332	CcSEcCtD
Orlistat—Drug interaction—Citalopram—alcohol dependence	0.00169	0.0033	CcSEcCtD
Orlistat—PLA2G4A—endocrine gland—alcohol dependence	0.00168	0.00639	CbGeAlD
Orlistat—Gastritis—Acamprosate—alcohol dependence	0.00168	0.00328	CcSEcCtD
Orlistat—Abdominal distension—Acamprosate—alcohol dependence	0.00165	0.00322	CcSEcCtD
Orlistat—Influenza—Acamprosate—alcohol dependence	0.00164	0.0032	CcSEcCtD
Orlistat—Asthma—Acamprosate—alcohol dependence	0.00164	0.0032	CcSEcCtD
Orlistat—Abdominal pain upper—Naltrexone—alcohol dependence	0.00164	0.0032	CcSEcCtD
Orlistat—Fatigue—Disulfiram—alcohol dependence	0.00163	0.00318	CcSEcCtD
Orlistat—Pain—Disulfiram—alcohol dependence	0.00162	0.00316	CcSEcCtD
Orlistat—Cramp muscle—Naltrexone—alcohol dependence	0.00162	0.00315	CcSEcCtD
Orlistat—Pancreatitis—Acamprosate—alcohol dependence	0.00161	0.00314	CcSEcCtD
Orlistat—PLA2G4A—testis—alcohol dependence	0.0016	0.0061	CbGeAlD
Orlistat—PLA2G4A—nervous system—alcohol dependence	0.00157	0.00598	CbGeAlD
Orlistat—Vaginal inflammation—Citalopram—alcohol dependence	0.00157	0.00306	CcSEcCtD
Orlistat—Influenza—Naltrexone—alcohol dependence	0.00155	0.00303	CcSEcCtD
Orlistat—Eructation—Citalopram—alcohol dependence	0.00154	0.003	CcSEcCtD
Orlistat—PLA2G4A—central nervous system—alcohol dependence	0.00151	0.00576	CbGeAlD
Orlistat—Sweating increased—Naltrexone—alcohol dependence	0.00151	0.00295	CcSEcCtD
Orlistat—Abdominal discomfort—Naltrexone—alcohol dependence	0.00149	0.0029	CcSEcCtD
Orlistat—Vaginal infection—Citalopram—alcohol dependence	0.00148	0.00289	CcSEcCtD
Orlistat—Depression—Acamprosate—alcohol dependence	0.00146	0.00284	CcSEcCtD
Orlistat—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00144	0.00281	CcSEcCtD
Orlistat—Cramps of lower extremities—Citalopram—alcohol dependence	0.00144	0.00281	CcSEcCtD
Orlistat—Urinary tract infection—Acamprosate—alcohol dependence	0.00142	0.00277	CcSEcCtD
Orlistat—Neoplasm—Citalopram—alcohol dependence	0.00142	0.00276	CcSEcCtD
Orlistat—Urine output increased—Citalopram—alcohol dependence	0.00142	0.00276	CcSEcCtD
Orlistat—Infestation NOS—Naltrexone—alcohol dependence	0.00138	0.0027	CcSEcCtD
Orlistat—Infestation—Naltrexone—alcohol dependence	0.00138	0.0027	CcSEcCtD
Orlistat—Depression—Naltrexone—alcohol dependence	0.00138	0.00269	CcSEcCtD
Orlistat—Asthenia—Disulfiram—alcohol dependence	0.00136	0.00265	CcSEcCtD
Orlistat—Urinary tract infection—Naltrexone—alcohol dependence	0.00134	0.00262	CcSEcCtD
Orlistat—Haemoglobin—Acamprosate—alcohol dependence	0.00132	0.00257	CcSEcCtD
Orlistat—Sleep disorder—Citalopram—alcohol dependence	0.00131	0.00256	CcSEcCtD
Orlistat—Haemorrhage—Acamprosate—alcohol dependence	0.00131	0.00256	CcSEcCtD
Orlistat—Hepatitis—Acamprosate—alcohol dependence	0.00131	0.00256	CcSEcCtD
Orlistat—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00131	0.00255	CcSEcCtD
Orlistat—Diabetes mellitus—Citalopram—alcohol dependence	0.00131	0.00255	CcSEcCtD
Orlistat—Pharyngitis—Acamprosate—alcohol dependence	0.0013	0.00254	CcSEcCtD
Orlistat—Sinusitis—Naltrexone—alcohol dependence	0.0013	0.00253	CcSEcCtD
Orlistat—Polyuria—Citalopram—alcohol dependence	0.00129	0.00253	CcSEcCtD
Orlistat—Oedema peripheral—Acamprosate—alcohol dependence	0.00129	0.00252	CcSEcCtD
Orlistat—Hepatic failure—Citalopram—alcohol dependence	0.00126	0.00247	CcSEcCtD
Orlistat—Eczema—Citalopram—alcohol dependence	0.00126	0.00247	CcSEcCtD
Orlistat—Dizziness—Disulfiram—alcohol dependence	0.00125	0.00244	CcSEcCtD
Orlistat—Hepatitis—Naltrexone—alcohol dependence	0.00124	0.00242	CcSEcCtD
Orlistat—Pharyngitis—Naltrexone—alcohol dependence	0.00123	0.0024	CcSEcCtD
Orlistat—Increased appetite—Citalopram—alcohol dependence	0.00121	0.00236	CcSEcCtD
Orlistat—Menopausal symptoms—Citalopram—alcohol dependence	0.0012	0.00235	CcSEcCtD
Orlistat—PLA2G4A—brain—alcohol dependence	0.0012	0.00457	CbGeAlD
Orlistat—Thirst—Citalopram—alcohol dependence	0.00119	0.00233	CcSEcCtD
Orlistat—Rash—Disulfiram—alcohol dependence	0.00119	0.00233	CcSEcCtD
Orlistat—Dermatitis bullous—Citalopram—alcohol dependence	0.00119	0.00232	CcSEcCtD
Orlistat—Headache—Disulfiram—alcohol dependence	0.00118	0.00231	CcSEcCtD
Orlistat—Immune system disorder—Acamprosate—alcohol dependence	0.00118	0.00231	CcSEcCtD
Orlistat—Arthritis—Citalopram—alcohol dependence	0.00117	0.00228	CcSEcCtD
Orlistat—Hypoglycaemia—Citalopram—alcohol dependence	0.00116	0.00227	CcSEcCtD
Orlistat—Alopecia—Acamprosate—alcohol dependence	0.00116	0.00226	CcSEcCtD
Orlistat—Mental disorder—Acamprosate—alcohol dependence	0.00115	0.00224	CcSEcCtD
Orlistat—Malnutrition—Acamprosate—alcohol dependence	0.00114	0.00223	CcSEcCtD
Orlistat—Osteoarthritis—Citalopram—alcohol dependence	0.00114	0.00222	CcSEcCtD
Orlistat—Flatulence—Acamprosate—alcohol dependence	0.00112	0.0022	CcSEcCtD
Orlistat—Immune system disorder—Naltrexone—alcohol dependence	0.00112	0.00219	CcSEcCtD
Orlistat—Mediastinal disorder—Naltrexone—alcohol dependence	0.00112	0.00218	CcSEcCtD
Orlistat—Dysgeusia—Acamprosate—alcohol dependence	0.00112	0.00218	CcSEcCtD
Orlistat—Back pain—Acamprosate—alcohol dependence	0.0011	0.00216	CcSEcCtD
Orlistat—Muscle spasms—Acamprosate—alcohol dependence	0.0011	0.00214	CcSEcCtD
Orlistat—Alopecia—Naltrexone—alcohol dependence	0.0011	0.00214	CcSEcCtD
Orlistat—Mental disorder—Naltrexone—alcohol dependence	0.00109	0.00212	CcSEcCtD
Orlistat—Malnutrition—Naltrexone—alcohol dependence	0.00108	0.00211	CcSEcCtD
Orlistat—Flatulence—Naltrexone—alcohol dependence	0.00106	0.00208	CcSEcCtD
Orlistat—Ill-defined disorder—Acamprosate—alcohol dependence	0.00106	0.00207	CcSEcCtD
Orlistat—Dysgeusia—Naltrexone—alcohol dependence	0.00106	0.00207	CcSEcCtD
Orlistat—Back pain—Naltrexone—alcohol dependence	0.00104	0.00204	CcSEcCtD
Orlistat—Angioedema—Acamprosate—alcohol dependence	0.00104	0.00204	CcSEcCtD
Orlistat—Dry skin—Citalopram—alcohol dependence	0.00104	0.00203	CcSEcCtD
Orlistat—Muscle spasms—Naltrexone—alcohol dependence	0.00104	0.00203	CcSEcCtD
Orlistat—Abdominal pain upper—Citalopram—alcohol dependence	0.00104	0.00203	CcSEcCtD
Orlistat—Hypokalaemia—Citalopram—alcohol dependence	0.00103	0.00202	CcSEcCtD
Orlistat—Malaise—Acamprosate—alcohol dependence	0.00103	0.00201	CcSEcCtD
Orlistat—Breast disorder—Citalopram—alcohol dependence	0.00103	0.00201	CcSEcCtD
Orlistat—Vertigo—Acamprosate—alcohol dependence	0.00103	0.002	CcSEcCtD
Orlistat—Cramp muscle—Citalopram—alcohol dependence	0.00102	0.002	CcSEcCtD
Orlistat—Vision blurred—Naltrexone—alcohol dependence	0.00102	0.00199	CcSEcCtD
Orlistat—Palpitations—Acamprosate—alcohol dependence	0.00101	0.00197	CcSEcCtD
Orlistat—Gastritis—Citalopram—alcohol dependence	0.00101	0.00196	CcSEcCtD
Orlistat—Ill-defined disorder—Naltrexone—alcohol dependence	0.001	0.00196	CcSEcCtD
Orlistat—Cough—Acamprosate—alcohol dependence	0.000996	0.00195	CcSEcCtD
Orlistat—Convulsion—Acamprosate—alcohol dependence	0.000989	0.00193	CcSEcCtD
Orlistat—Abdominal distension—Citalopram—alcohol dependence	0.000989	0.00193	CcSEcCtD
Orlistat—Angioedema—Naltrexone—alcohol dependence	0.000987	0.00193	CcSEcCtD
Orlistat—Asthma—Citalopram—alcohol dependence	0.000982	0.00192	CcSEcCtD
Orlistat—Influenza—Citalopram—alcohol dependence	0.000982	0.00192	CcSEcCtD
Orlistat—Malaise—Naltrexone—alcohol dependence	0.000974	0.0019	CcSEcCtD
Orlistat—Chest pain—Acamprosate—alcohol dependence	0.000972	0.0019	CcSEcCtD
Orlistat—Myalgia—Acamprosate—alcohol dependence	0.000972	0.0019	CcSEcCtD
Orlistat—Anxiety—Acamprosate—alcohol dependence	0.000969	0.00189	CcSEcCtD
Orlistat—Bronchospasm—Citalopram—alcohol dependence	0.000966	0.00189	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000965	0.00188	CcSEcCtD
Orlistat—Pancreatitis—Citalopram—alcohol dependence	0.000963	0.00188	CcSEcCtD
Orlistat—Discomfort—Acamprosate—alcohol dependence	0.00096	0.00187	CcSEcCtD
Orlistat—Sweating increased—Citalopram—alcohol dependence	0.000957	0.00187	CcSEcCtD
Orlistat—Palpitations—Naltrexone—alcohol dependence	0.000955	0.00186	CcSEcCtD
Orlistat—Dry mouth—Acamprosate—alcohol dependence	0.000951	0.00186	CcSEcCtD
Orlistat—Cough—Naltrexone—alcohol dependence	0.000943	0.00184	CcSEcCtD
Orlistat—Abdominal discomfort—Citalopram—alcohol dependence	0.000942	0.00184	CcSEcCtD
Orlistat—Convulsion—Naltrexone—alcohol dependence	0.000936	0.00183	CcSEcCtD
Orlistat—Anaphylactic shock—Acamprosate—alcohol dependence	0.000932	0.00182	CcSEcCtD
Orlistat—Infection—Acamprosate—alcohol dependence	0.000926	0.00181	CcSEcCtD
Orlistat—Chest pain—Naltrexone—alcohol dependence	0.00092	0.0018	CcSEcCtD
Orlistat—Myalgia—Naltrexone—alcohol dependence	0.00092	0.0018	CcSEcCtD
Orlistat—Anxiety—Naltrexone—alcohol dependence	0.000916	0.00179	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000913	0.00178	CcSEcCtD
Orlistat—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000913	0.00178	CcSEcCtD
Orlistat—Discomfort—Naltrexone—alcohol dependence	0.000909	0.00177	CcSEcCtD
Orlistat—Skin disorder—Acamprosate—alcohol dependence	0.000905	0.00177	CcSEcCtD
Orlistat—Hyperhidrosis—Acamprosate—alcohol dependence	0.000901	0.00176	CcSEcCtD
Orlistat—Dry mouth—Naltrexone—alcohol dependence	0.000899	0.00176	CcSEcCtD
Orlistat—Anaphylactic shock—Naltrexone—alcohol dependence	0.000882	0.00172	CcSEcCtD
Orlistat—Oedema—Naltrexone—alcohol dependence	0.000882	0.00172	CcSEcCtD
Orlistat—Infection—Naltrexone—alcohol dependence	0.000876	0.00171	CcSEcCtD
Orlistat—Infestation NOS—Citalopram—alcohol dependence	0.000876	0.00171	CcSEcCtD
Orlistat—Infestation—Citalopram—alcohol dependence	0.000876	0.00171	CcSEcCtD
Orlistat—Depression—Citalopram—alcohol dependence	0.000873	0.0017	CcSEcCtD
Orlistat—Nervous system disorder—Naltrexone—alcohol dependence	0.000865	0.00169	CcSEcCtD
Orlistat—Neuropathy peripheral—Citalopram—alcohol dependence	0.000858	0.00168	CcSEcCtD
Orlistat—Skin disorder—Naltrexone—alcohol dependence	0.000856	0.00167	CcSEcCtD
Orlistat—Hyperhidrosis—Naltrexone—alcohol dependence	0.000852	0.00166	CcSEcCtD
Orlistat—Urinary tract infection—Citalopram—alcohol dependence	0.000851	0.00166	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000849	0.00166	CcSEcCtD
Orlistat—Insomnia—Acamprosate—alcohol dependence	0.000843	0.00165	CcSEcCtD
Orlistat—Paraesthesia—Acamprosate—alcohol dependence	0.000837	0.00163	CcSEcCtD
Orlistat—Hepatobiliary disease—Citalopram—alcohol dependence	0.000828	0.00162	CcSEcCtD
Orlistat—Sinusitis—Citalopram—alcohol dependence	0.000822	0.0016	CcSEcCtD
Orlistat—Dyspepsia—Acamprosate—alcohol dependence	0.00082	0.0016	CcSEcCtD
Orlistat—Decreased appetite—Acamprosate—alcohol dependence	0.00081	0.00158	CcSEcCtD
Orlistat—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000804	0.00157	CcSEcCtD
Orlistat—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000803	0.00157	CcSEcCtD
Orlistat—Insomnia—Naltrexone—alcohol dependence	0.000797	0.00156	CcSEcCtD
Orlistat—Pain—Acamprosate—alcohol dependence	0.000797	0.00156	CcSEcCtD
Orlistat—Paraesthesia—Naltrexone—alcohol dependence	0.000792	0.00155	CcSEcCtD
Orlistat—Haemoglobin—Citalopram—alcohol dependence	0.00079	0.00154	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—OPRK1—alcohol dependence	0.000787	0.00434	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—OPRK1—alcohol dependence	0.000787	0.00434	CbGpPWpGaD
Orlistat—Hepatitis—Citalopram—alcohol dependence	0.000786	0.00153	CcSEcCtD
Orlistat—Haemorrhage—Citalopram—alcohol dependence	0.000786	0.00153	CcSEcCtD
Orlistat—Pharyngitis—Citalopram—alcohol dependence	0.00078	0.00152	CcSEcCtD
Orlistat—Urinary tract disorder—Citalopram—alcohol dependence	0.000776	0.00152	CcSEcCtD
Orlistat—Oedema peripheral—Citalopram—alcohol dependence	0.000775	0.00151	CcSEcCtD
Orlistat—Urethral disorder—Citalopram—alcohol dependence	0.000771	0.0015	CcSEcCtD
Orlistat—Feeling abnormal—Acamprosate—alcohol dependence	0.000768	0.0015	CcSEcCtD
Orlistat—Decreased appetite—Naltrexone—alcohol dependence	0.000766	0.0015	CcSEcCtD
Orlistat—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000762	0.00149	CcSEcCtD
Orlistat—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000761	0.00149	CcSEcCtD
Orlistat—Fatigue—Naltrexone—alcohol dependence	0.00076	0.00148	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—OPRM1—alcohol dependence	0.000759	0.00418	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—OPRM1—alcohol dependence	0.000759	0.00418	CbGpPWpGaD
Orlistat—Pain—Naltrexone—alcohol dependence	0.000754	0.00147	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—CHRM2—alcohol dependence	0.000751	0.00414	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CHRM2—alcohol dependence	0.000751	0.00414	CbGpPWpGaD
Orlistat—Urticaria—Acamprosate—alcohol dependence	0.00074	0.00145	CcSEcCtD
Orlistat—Abdominal pain—Acamprosate—alcohol dependence	0.000737	0.00144	CcSEcCtD
Orlistat—Body temperature increased—Acamprosate—alcohol dependence	0.000737	0.00144	CcSEcCtD
Orlistat—FASN—Metabolism—ADH6—alcohol dependence	0.000729	0.00401	CbGpPWpGaD
Orlistat—Feeling abnormal—Naltrexone—alcohol dependence	0.000726	0.00142	CcSEcCtD
Orlistat—PNLIP—Metabolism—ADH4—alcohol dependence	0.000725	0.004	CbGpPWpGaD
Orlistat—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000721	0.00141	CcSEcCtD
Orlistat—Immune system disorder—Citalopram—alcohol dependence	0.00071	0.00139	CcSEcCtD
Orlistat—Mediastinal disorder—Citalopram—alcohol dependence	0.000709	0.00138	CcSEcCtD
Orlistat—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000708	0.0039	CbGpPWpGaD
Orlistat—Urticaria—Naltrexone—alcohol dependence	0.0007	0.00137	CcSEcCtD
Orlistat—DAGLB—GPCR downstream signaling—NPY—alcohol dependence	0.000699	0.00385	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—NPY—alcohol dependence	0.000699	0.00385	CbGpPWpGaD
Orlistat—Body temperature increased—Naltrexone—alcohol dependence	0.000697	0.00136	CcSEcCtD
Orlistat—Abdominal pain—Naltrexone—alcohol dependence	0.000697	0.00136	CcSEcCtD
Orlistat—Alopecia—Citalopram—alcohol dependence	0.000695	0.00136	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—OPRM1—alcohol dependence	0.000689	0.0038	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—OPRM1—alcohol dependence	0.000689	0.0038	CbGpPWpGaD
Orlistat—Mental disorder—Citalopram—alcohol dependence	0.000689	0.00134	CcSEcCtD
Orlistat—Hypersensitivity—Acamprosate—alcohol dependence	0.000686	0.00134	CcSEcCtD
Orlistat—Malnutrition—Citalopram—alcohol dependence	0.000684	0.00134	CcSEcCtD
Orlistat—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000681	0.00375	CbGpPWpGaD
Orlistat—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000678	0.00373	CbGpPWpGaD
Orlistat—Flatulence—Citalopram—alcohol dependence	0.000674	0.00132	CcSEcCtD
Orlistat—DAGLA—GPCR downstream signaling—CRH—alcohol dependence	0.000674	0.00371	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR1B—alcohol dependence	0.000674	0.00371	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CRH—alcohol dependence	0.000674	0.00371	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—HTR1B—alcohol dependence	0.000674	0.00371	CbGpPWpGaD
Orlistat—CYP3A4—digestive system—alcohol dependence	0.000671	0.00255	CbGeAlD
Orlistat—Dysgeusia—Citalopram—alcohol dependence	0.00067	0.00131	CcSEcCtD
Orlistat—Asthenia—Acamprosate—alcohol dependence	0.000669	0.00131	CcSEcCtD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000668	0.00368	CbGpPWpGaD
Orlistat—Back pain—Citalopram—alcohol dependence	0.000662	0.00129	CcSEcCtD
Orlistat—Pruritus—Acamprosate—alcohol dependence	0.000659	0.00129	CcSEcCtD
Orlistat—Muscle spasms—Citalopram—alcohol dependence	0.000658	0.00128	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—OPRK1—alcohol dependence	0.000653	0.00359	CbGpPWpGaD
Orlistat—Hypersensitivity—Naltrexone—alcohol dependence	0.00065	0.00127	CcSEcCtD
Orlistat—Vision blurred—Citalopram—alcohol dependence	0.000645	0.00126	CcSEcCtD
Orlistat—CYP3A4—blood—alcohol dependence	0.000639	0.00243	CbGeAlD
Orlistat—Diarrhoea—Acamprosate—alcohol dependence	0.000638	0.00124	CcSEcCtD
Orlistat—Ill-defined disorder—Citalopram—alcohol dependence	0.000635	0.00124	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—NPY—alcohol dependence	0.000634	0.00349	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—NPY—alcohol dependence	0.000634	0.00349	CbGpPWpGaD
Orlistat—Asthenia—Naltrexone—alcohol dependence	0.000633	0.00123	CcSEcCtD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000628	0.00346	CbGpPWpGaD
Orlistat—Angioedema—Citalopram—alcohol dependence	0.000625	0.00122	CcSEcCtD
Orlistat—Pruritus—Naltrexone—alcohol dependence	0.000624	0.00122	CcSEcCtD
Orlistat—Malaise—Citalopram—alcohol dependence	0.000617	0.00121	CcSEcCtD
Orlistat—PNLIP—Metabolism—ADH7—alcohol dependence	0.000617	0.0034	CbGpPWpGaD
Orlistat—Dizziness—Acamprosate—alcohol dependence	0.000616	0.0012	CcSEcCtD
Orlistat—Vertigo—Citalopram—alcohol dependence	0.000615	0.0012	CcSEcCtD
Orlistat—DAGLB—Signaling by GPCR—HTR1B—alcohol dependence	0.000612	0.00337	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CRH—alcohol dependence	0.000612	0.00337	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HTR1B—alcohol dependence	0.000612	0.00337	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CRH—alcohol dependence	0.000612	0.00337	CbGpPWpGaD
Orlistat—Palpitations—Citalopram—alcohol dependence	0.000605	0.00118	CcSEcCtD
Orlistat—FASN—Metabolism—ADH1A—alcohol dependence	0.000604	0.00333	CbGpPWpGaD
Orlistat—Diarrhoea—Naltrexone—alcohol dependence	0.000603	0.00118	CcSEcCtD
Orlistat—Cough—Citalopram—alcohol dependence	0.000597	0.00117	CcSEcCtD
Orlistat—Convulsion—Citalopram—alcohol dependence	0.000593	0.00116	CcSEcCtD
Orlistat—Vomiting—Acamprosate—alcohol dependence	0.000592	0.00116	CcSEcCtD
Orlistat—PNLIP—Metabolism—GGT2—alcohol dependence	0.000591	0.00326	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—DRD4—alcohol dependence	0.000589	0.00325	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—DRD4—alcohol dependence	0.000589	0.00325	CbGpPWpGaD
Orlistat—Rash—Acamprosate—alcohol dependence	0.000587	0.00115	CcSEcCtD
Orlistat—Dermatitis—Acamprosate—alcohol dependence	0.000587	0.00115	CcSEcCtD
Orlistat—Headache—Acamprosate—alcohol dependence	0.000584	0.00114	CcSEcCtD
Orlistat—Dizziness—Naltrexone—alcohol dependence	0.000583	0.00114	CcSEcCtD
Orlistat—Myalgia—Citalopram—alcohol dependence	0.000583	0.00114	CcSEcCtD
Orlistat—Chest pain—Citalopram—alcohol dependence	0.000583	0.00114	CcSEcCtD
Orlistat—Anxiety—Citalopram—alcohol dependence	0.000581	0.00113	CcSEcCtD
Orlistat—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000579	0.00113	CcSEcCtD
Orlistat—Discomfort—Citalopram—alcohol dependence	0.000576	0.00112	CcSEcCtD
Orlistat—Dry mouth—Citalopram—alcohol dependence	0.00057	0.00111	CcSEcCtD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000568	0.00313	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CNR1—alcohol dependence	0.000563	0.0031	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CNR1—alcohol dependence	0.000563	0.0031	CbGpPWpGaD
Orlistat—Vomiting—Naltrexone—alcohol dependence	0.000561	0.00109	CcSEcCtD
Orlistat—Oedema—Citalopram—alcohol dependence	0.000559	0.00109	CcSEcCtD
Orlistat—Anaphylactic shock—Citalopram—alcohol dependence	0.000559	0.00109	CcSEcCtD
Orlistat—Rash—Naltrexone—alcohol dependence	0.000556	0.00109	CcSEcCtD
Orlistat—Dermatitis—Naltrexone—alcohol dependence	0.000555	0.00108	CcSEcCtD
Orlistat—Infection—Citalopram—alcohol dependence	0.000555	0.00108	CcSEcCtD
Orlistat—CYP3A4—endocrine gland—alcohol dependence	0.000555	0.00211	CbGeAlD
Orlistat—Nausea—Acamprosate—alcohol dependence	0.000553	0.00108	CcSEcCtD
Orlistat—Headache—Naltrexone—alcohol dependence	0.000552	0.00108	CcSEcCtD
Orlistat—DAGLB—GPCR downstream signaling—HTR7—alcohol dependence	0.000549	0.00302	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—DRD2—alcohol dependence	0.000549	0.00302	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—DRD2—alcohol dependence	0.000549	0.00302	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—HTR7—alcohol dependence	0.000549	0.00302	CbGpPWpGaD
Orlistat—Nervous system disorder—Citalopram—alcohol dependence	0.000548	0.00107	CcSEcCtD
Orlistat—Skin disorder—Citalopram—alcohol dependence	0.000543	0.00106	CcSEcCtD
Orlistat—PNLIP—Metabolism—ADH1B—alcohol dependence	0.000541	0.00298	CbGpPWpGaD
Orlistat—Hyperhidrosis—Citalopram—alcohol dependence	0.00054	0.00105	CcSEcCtD
Orlistat—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000535	0.00295	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—DRD4—alcohol dependence	0.000535	0.00295	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—DRD4—alcohol dependence	0.000535	0.00295	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—OPRD1—alcohol dependence	0.000529	0.00292	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—OPRD1—alcohol dependence	0.000529	0.00292	CbGpPWpGaD
Orlistat—PLA2G4A—Opioid Signalling—POMC—alcohol dependence	0.000529	0.00292	CbGpPWpGaD
Orlistat—Nausea—Naltrexone—alcohol dependence	0.000524	0.00102	CcSEcCtD
Orlistat—CYP3A4—nervous system—alcohol dependence	0.000519	0.00197	CbGeAlD
Orlistat—FASN—Metabolism—ADH4—alcohol dependence	0.000513	0.00283	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CNR1—alcohol dependence	0.000511	0.00281	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CNR1—alcohol dependence	0.000511	0.00281	CbGpPWpGaD
Orlistat—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000509	0.000994	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—PDYN—alcohol dependence	0.000507	0.0028	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—PDYN—alcohol dependence	0.000507	0.0028	CbGpPWpGaD
Orlistat—Insomnia—Citalopram—alcohol dependence	0.000505	0.000986	CcSEcCtD
Orlistat—PLA2G7—Metabolism of proteins—POMC—alcohol dependence	0.000504	0.00278	CbGpPWpGaD
Orlistat—Paraesthesia—Citalopram—alcohol dependence	0.000502	0.000979	CcSEcCtD
Orlistat—CYP3A4—liver—alcohol dependence	0.0005	0.0019	CbGeAlD
Orlistat—CYP3A4—central nervous system—alcohol dependence	0.0005	0.0019	CbGeAlD
Orlistat—DAGLB—Signaling by GPCR—HTR7—alcohol dependence	0.000498	0.00275	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—DRD2—alcohol dependence	0.000498	0.00275	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—DRD2—alcohol dependence	0.000498	0.00275	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—HTR7—alcohol dependence	0.000498	0.00275	CbGpPWpGaD
Orlistat—Dyspepsia—Citalopram—alcohol dependence	0.000492	0.00096	CcSEcCtD
Orlistat—Decreased appetite—Citalopram—alcohol dependence	0.000486	0.000948	CcSEcCtD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000483	0.00266	CbGpPWpGaD
Orlistat—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000482	0.000942	CcSEcCtD
Orlistat—Fatigue—Citalopram—alcohol dependence	0.000482	0.00094	CcSEcCtD
Orlistat—Pain—Citalopram—alcohol dependence	0.000478	0.000933	CcSEcCtD
Orlistat—DAGLB—Signaling Pathways—WASF2—alcohol dependence	0.000472	0.0026	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—WASF2—alcohol dependence	0.000472	0.0026	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CRHR1—alcohol dependence	0.000472	0.0026	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CRHR1—alcohol dependence	0.000472	0.0026	CbGpPWpGaD
Orlistat—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000463	0.00255	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—AVP—alcohol dependence	0.000462	0.00254	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—AVP—alcohol dependence	0.000462	0.00254	CbGpPWpGaD
Orlistat—Feeling abnormal—Citalopram—alcohol dependence	0.00046	0.000899	CcSEcCtD
Orlistat—Gastrointestinal pain—Citalopram—alcohol dependence	0.000457	0.000892	CcSEcCtD
Orlistat—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000455	0.00251	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—WASF1—alcohol dependence	0.000452	0.00249	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—WASF1—alcohol dependence	0.000452	0.00249	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—MAOB—alcohol dependence	0.000448	0.00247	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000444	0.00245	CbGpPWpGaD
Orlistat—Urticaria—Citalopram—alcohol dependence	0.000444	0.000866	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—CHRM2—alcohol dependence	0.000444	0.00244	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CHRM2—alcohol dependence	0.000444	0.00244	CbGpPWpGaD
Orlistat—Abdominal pain—Citalopram—alcohol dependence	0.000442	0.000862	CcSEcCtD
Orlistat—Body temperature increased—Citalopram—alcohol dependence	0.000442	0.000862	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—OPRD1—alcohol dependence	0.000439	0.00242	CbGpPWpGaD
Orlistat—FASN—Metabolism—ADH7—alcohol dependence	0.000436	0.0024	CbGpPWpGaD
Orlistat—FASN—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	0.000432	0.00238	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000428	0.00236	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000423	0.00233	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—PDYN—alcohol dependence	0.00042	0.00232	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—AVP—alcohol dependence	0.00042	0.00231	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—AVP—alcohol dependence	0.00042	0.00231	CbGpPWpGaD
Orlistat—FASN—Metabolism—GGT2—alcohol dependence	0.000418	0.00231	CbGpPWpGaD
Orlistat—Hypersensitivity—Citalopram—alcohol dependence	0.000412	0.000803	CcSEcCtD
Orlistat—DAGLA—Signaling Pathways—OPRM1—alcohol dependence	0.000407	0.00224	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—OPRM1—alcohol dependence	0.000407	0.00224	CbGpPWpGaD
Orlistat—Asthenia—Citalopram—alcohol dependence	0.000401	0.000782	CcSEcCtD
Orlistat—Pruritus—Citalopram—alcohol dependence	0.000395	0.000772	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CRHR1—alcohol dependence	0.000391	0.00215	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—WASF2—alcohol dependence	0.000391	0.00215	CbGpPWpGaD
Orlistat—PNLIP—Disease—GOT2—alcohol dependence	0.000387	0.00213	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—HTR2A—alcohol dependence	0.000384	0.00212	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—HTR2A—alcohol dependence	0.000384	0.00212	CbGpPWpGaD
Orlistat—FASN—Metabolism—ADH1B—alcohol dependence	0.000383	0.00211	CbGpPWpGaD
Orlistat—Diarrhoea—Citalopram—alcohol dependence	0.000382	0.000746	CcSEcCtD
Orlistat—PNLIP—Metabolism—ALDH2—alcohol dependence	0.000381	0.0021	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—NPY—alcohol dependence	0.000375	0.00206	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—NPY—alcohol dependence	0.000375	0.00206	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—WASF1—alcohol dependence	0.000375	0.00206	CbGpPWpGaD
Orlistat—Dizziness—Citalopram—alcohol dependence	0.000369	0.000721	CcSEcCtD
Orlistat—PNLIP—Signaling Pathways—CHRM2—alcohol dependence	0.000368	0.00202	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000366	0.00202	CbGpPWpGaD
Orlistat—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000364	0.002	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR1B—alcohol dependence	0.000362	0.00199	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CRH—alcohol dependence	0.000362	0.00199	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR1B—alcohol dependence	0.000362	0.00199	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CRH—alcohol dependence	0.000362	0.00199	CbGpPWpGaD
Orlistat—Vomiting—Citalopram—alcohol dependence	0.000355	0.000693	CcSEcCtD
Orlistat—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000355	0.00195	CbGpPWpGaD
Orlistat—Rash—Citalopram—alcohol dependence	0.000352	0.000688	CcSEcCtD
Orlistat—Dermatitis—Citalopram—alcohol dependence	0.000352	0.000687	CcSEcCtD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000351	0.00193	CbGpPWpGaD
Orlistat—Headache—Citalopram—alcohol dependence	0.00035	0.000683	CcSEcCtD
Orlistat—DAGLA—Signaling by GPCR—HTR2A—alcohol dependence	0.000349	0.00192	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—HTR2A—alcohol dependence	0.000349	0.00192	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—OPRM1—alcohol dependence	0.000337	0.00186	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OPRK1—alcohol dependence	0.000335	0.00185	CbGpPWpGaD
Orlistat—PNLIP—Disease—GOT1—alcohol dependence	0.000334	0.00184	CbGpPWpGaD
Orlistat—Nausea—Citalopram—alcohol dependence	0.000332	0.000648	CcSEcCtD
Orlistat—PNLIP—Metabolism—GOT2—alcohol dependence	0.000324	0.00179	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—EP300—alcohol dependence	0.000322	0.00178	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—EP300—alcohol dependence	0.000322	0.00178	CbGpPWpGaD
Orlistat—FASN—Metabolism—MAOB—alcohol dependence	0.000317	0.00175	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—DRD4—alcohol dependence	0.000316	0.00174	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—DRD4—alcohol dependence	0.000316	0.00174	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADH6—alcohol dependence	0.000313	0.00172	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—NPY—alcohol dependence	0.000311	0.00171	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—POMC—alcohol dependence	0.000307	0.00169	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—POMC—alcohol dependence	0.000307	0.00169	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—CYP2E1—alcohol dependence	0.000305	0.00168	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CNR1—alcohol dependence	0.000302	0.00166	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CNR1—alcohol dependence	0.000302	0.00166	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000302	0.00166	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR1B—alcohol dependence	0.0003	0.00165	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CRH—alcohol dependence	0.0003	0.00165	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000298	0.00164	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—DRD2—alcohol dependence	0.000294	0.00162	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR7—alcohol dependence	0.000294	0.00162	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR7—alcohol dependence	0.000294	0.00162	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—DRD2—alcohol dependence	0.000294	0.00162	CbGpPWpGaD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000294	0.00162	CbGpPWpGaD
Orlistat—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00029	0.0016	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GOT1—alcohol dependence	0.00028	0.00154	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GGT1—alcohol dependence	0.00028	0.00154	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—POMC—alcohol dependence	0.000279	0.00154	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—POMC—alcohol dependence	0.000279	0.00154	CbGpPWpGaD
Orlistat—FASN—Disease—GOT2—alcohol dependence	0.000274	0.00151	CbGpPWpGaD
Orlistat—FASN—Metabolism—ALDH2—alcohol dependence	0.00027	0.00149	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DRD4—alcohol dependence	0.000262	0.00144	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000259	0.00143	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADH1A—alcohol dependence	0.000259	0.00143	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000256	0.00141	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—MAOA—alcohol dependence	0.000251	0.00138	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CNR1—alcohol dependence	0.00025	0.00138	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—AVP—alcohol dependence	0.000248	0.00137	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—AVP—alcohol dependence	0.000248	0.00137	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000246	0.00135	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—DRD2—alcohol dependence	0.000244	0.00134	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR7—alcohol dependence	0.000244	0.00134	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000243	0.00134	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000238	0.00131	CbGpPWpGaD
Orlistat—FASN—Disease—GOT1—alcohol dependence	0.000236	0.0013	CbGpPWpGaD
Orlistat—FASN—Metabolism—GOT2—alcohol dependence	0.000229	0.00126	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OPRD1—alcohol dependence	0.000225	0.00124	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000225	0.00124	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADH4—alcohol dependence	0.00022	0.00121	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—PDYN—alcohol dependence	0.000216	0.00119	CbGpPWpGaD
Orlistat—FASN—Metabolism—CYP2E1—alcohol dependence	0.000216	0.00119	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—HTR2A—alcohol dependence	0.000206	0.00114	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—HTR2A—alcohol dependence	0.000206	0.00114	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—AVP—alcohol dependence	0.000205	0.00113	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CRHR1—alcohol dependence	0.000201	0.00111	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OPRK1—alcohol dependence	0.000198	0.00109	CbGpPWpGaD
Orlistat—FASN—Metabolism—GOT1—alcohol dependence	0.000198	0.00109	CbGpPWpGaD
Orlistat—FASN—Metabolism—GGT1—alcohol dependence	0.000198	0.00109	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000196	0.00108	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000191	0.00105	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CHRM2—alcohol dependence	0.000189	0.00104	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADH7—alcohol dependence	0.000187	0.00103	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000186	0.00103	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GGT2—alcohol dependence	0.00018	0.000989	CbGpPWpGaD
Orlistat—FASN—Metabolism—MAOA—alcohol dependence	0.000177	0.000977	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000177	0.000974	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—OPRM1—alcohol dependence	0.000173	0.000955	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000172	0.000947	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—HTR2A—alcohol dependence	0.000171	0.000941	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—POMC—alcohol dependence	0.000165	0.000907	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—POMC—alcohol dependence	0.000165	0.000907	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ADH1B—alcohol dependence	0.000164	0.000905	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—POMC—alcohol dependence	0.000163	0.000899	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—NPY—alcohol dependence	0.00016	0.000879	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000158	0.000873	CbGpPWpGaD
Orlistat—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000158	0.000868	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR1B—alcohol dependence	0.000154	0.000848	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CRH—alcohol dependence	0.000154	0.000848	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—POMC—alcohol dependence	0.000136	0.000752	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MAOB—alcohol dependence	0.000136	0.00075	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD4—alcohol dependence	0.000135	0.000741	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OPRD1—alcohol dependence	0.000133	0.000734	CbGpPWpGaD
Orlistat—PNLIP—Disease—EP300—alcohol dependence	0.000129	0.000712	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CNR1—alcohol dependence	0.000129	0.000708	CbGpPWpGaD
Orlistat—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000128	0.000704	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—PDYN—alcohol dependence	0.000128	0.000703	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000127	0.000698	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—DRD2—alcohol dependence	0.000125	0.000691	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR7—alcohol dependence	0.000125	0.000691	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000125	0.000688	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CRHR1—alcohol dependence	0.000119	0.000654	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—WASF2—alcohol dependence	0.000119	0.000654	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000116	0.000641	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—ALDH2—alcohol dependence	0.000116	0.000637	CbGpPWpGaD
Orlistat—FASN—Metabolism—POMC—alcohol dependence	0.000115	0.000636	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—WASF1—alcohol dependence	0.000114	0.000627	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CHRM2—alcohol dependence	0.000112	0.000615	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000111	0.000613	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—EP300—alcohol dependence	0.000109	0.000602	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—EP300—alcohol dependence	0.000109	0.000602	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—EP300—alcohol dependence	0.000108	0.000596	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—AVP—alcohol dependence	0.000106	0.000581	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000104	0.000574	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—OPRM1—alcohol dependence	0.000102	0.000564	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GOT2—alcohol dependence	9.84e-05	0.000542	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—NPY—alcohol dependence	9.43e-05	0.000519	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—CYP2E1—alcohol dependence	9.25e-05	0.00051	CbGpPWpGaD
Orlistat—FASN—Disease—EP300—alcohol dependence	9.15e-05	0.000504	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CRH—alcohol dependence	9.1e-05	0.000501	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR1B—alcohol dependence	9.1e-05	0.000501	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—EP300—alcohol dependence	9.05e-05	0.000499	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—HTR2A—alcohol dependence	8.78e-05	0.000484	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GOT1—alcohol dependence	8.49e-05	0.000468	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GGT1—alcohol dependence	8.49e-05	0.000468	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—EP300—alcohol dependence	8.11e-05	0.000447	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD4—alcohol dependence	7.95e-05	0.000438	CbGpPWpGaD
Orlistat—FASN—Metabolism—EP300—alcohol dependence	7.66e-05	0.000422	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—MAOA—alcohol dependence	7.61e-05	0.000419	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CNR1—alcohol dependence	7.59e-05	0.000418	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—DRD2—alcohol dependence	7.41e-05	0.000408	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR7—alcohol dependence	7.41e-05	0.000408	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	7.38e-05	0.000407	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADH6—alcohol dependence	7.32e-05	0.000403	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—POMC—alcohol dependence	7.01e-05	0.000386	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.79e-05	0.000374	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—AVP—alcohol dependence	6.23e-05	0.000343	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADH1A—alcohol dependence	6.07e-05	0.000334	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—HTR2A—alcohol dependence	5.19e-05	0.000286	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADH4—alcohol dependence	5.16e-05	0.000284	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—POMC—alcohol dependence	4.95e-05	0.000273	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADH7—alcohol dependence	4.39e-05	0.000242	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GGT2—alcohol dependence	4.21e-05	0.000232	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—POMC—alcohol dependence	4.14e-05	0.000228	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.85e-05	0.000212	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—EP300—alcohol dependence	3.29e-05	0.000181	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MAOB—alcohol dependence	3.19e-05	0.000176	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—EP300—alcohol dependence	2.75e-05	0.000151	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.71e-05	0.000149	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GOT2—alcohol dependence	2.3e-05	0.000127	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.17e-05	0.000119	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GOT1—alcohol dependence	1.99e-05	0.00011	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GGT1—alcohol dependence	1.99e-05	0.00011	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—MAOA—alcohol dependence	1.78e-05	9.82e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—POMC—alcohol dependence	1.16e-05	6.39e-05	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—EP300—alcohol dependence	7.7e-06	4.24e-05	CbGpPWpGaD
